Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,223 | 76,957 | 93,414 | 106,144 | 45,856 |
| TOTAL | $65,110 | $80,589 | $95,412 | $107,616 | $47,158 |
| Non-Current Assets | |||||
| PPE Net | 110 | 129 | 148 | 110 | 125 |
| Other Non-Current Assets | 2,003 | 2,061 | 1,529 | 57 | 176 |
| TOTAL | $2,113 | $2,190 | $1,677 | $167 | $301 |
| Total Assets | $67,223 | $82,779 | $97,089 | $107,783 | $47,459 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,084 | 9,989 | 5,491 | 5,301 | 5,023 |
| Accrued Expenses | 10,563 | 10,762 | 7,501 | 3,869 | 4,009 |
| TOTAL | $23,647 | $20,751 | $12,992 | $9,170 | $9,032 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,476 | 1,037 | 0 | 0 | 0 |
| TOTAL | $1,476 | $1,037 | $N/A | $N/A | $N/A |
| Total Liabilities | $25,123 | $21,788 | $12,992 | $9,170 | $9,032 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,479 | 13,886 | 12,527 | 12,433 | 6,583 |
| Common Shares | 14 | 13 | 13 | 12 | 6 |
| Retained earnings | -245,509 | -223,373 | -198,585 | -180,903 | -169,654 |
| Other shareholders' equity | -4 | 3 | -6 | 0 | 0 |
| TOTAL | $42,100 | $60,991 | $84,097 | $98,613 | $38,427 |
| Total Liabilities And Equity | $67,223 | $82,779 | $97,089 | $107,783 | $47,459 |